P 11187
Alternative Names: P11187Latest Information Update: 16 Jul 2016
At a glance
- Originator Piramal Enterprises
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action FFAR1 protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Type-2-diabetes-mellitus(In volunteers) in USA (PO, Capsule)
- 17 Jun 2014 Pharmacodynamics data from a preclinical trial in type 2 diabetes mellitus presented at the 74th Annual Scientific Sessions of the American Diabetes Association (ADA-2014)
- 01 Jun 2013 Phase-I clinical trials in Type-2 diabetes mellitus (in volunteers) in USA (PO)